Laurent Moll Sells 5,599 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) COO Laurent Moll sold 5,599 shares of Arteris stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $38.78, for a total value of $217,129.22. Following the completion of the sale, the chief operating officer directly owned 221,697 shares of the company’s stock, valued at $8,597,409.66. The trade was a 2.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Arteris Price Performance

AIP stock opened at $31.32 on Wednesday. The business’s fifty day moving average price is $36.62 and its 200 day moving average price is $23.79. Arteris, Inc. has a 12-month low of $8.42 and a 12-month high of $50.26. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $1.45 billion, a PE ratio of -39.65 and a beta of 1.92.

Arteris (NASDAQ:AIP) last released its earnings results on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.05. The firm had revenue of $22.94 million during the quarter, compared to analyst estimates of $21.03 million. On average, sell-side analysts anticipate that Arteris, Inc. will post -0.54 EPS for the current year.

Institutional Investors Weigh In On Arteris

Several institutional investors have recently added to or reduced their stakes in AIP. Westerly Capital Management LLC raised its holdings in Arteris by 109.6% during the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after purchasing an additional 745,000 shares in the last quarter. Nuveen LLC boosted its holdings in shares of Arteris by 872.3% in the 4th quarter. Nuveen LLC now owns 737,281 shares of the company’s stock valued at $11,428,000 after buying an additional 661,454 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Arteris by 144.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock valued at $15,696,000 after buying an additional 598,840 shares in the last quarter. Granahan Investment Management LLC grew its position in shares of Arteris by 725.7% in the 3rd quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock valued at $6,278,000 after buying an additional 546,341 shares during the last quarter. Finally, Informed Momentum Co LLC purchased a new position in shares of Arteris in the 4th quarter valued at $5,755,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

More Arteris News

Here are the key news stories impacting Arteris this week:

• Neutral Sentiment: Several Arteris insiders disclosed planned share sales tied to equity vesting and tax withholding obligations, including CEO K. Charles Janac, CFO Nicholas B. Hawkins, COO Laurent R. Moll, and VP Paul Alpern. These trades can weigh on sentiment because they increase near-term selling pressure, but they were not described as discretionary bearish bets. Article Title
• Neutral Sentiment: Despite the insider sales, the transactions were largely routine: the company said the shares were sold to cover tax obligations related to vesting equity awards. That limits how negative investors may view the filings, since the sales do not necessarily signal a change in management’s outlook. Article Title
• Positive Sentiment: Arteris’ last quarterly report was stronger than expected, with earnings per share of -$0.03 versus estimates for -$0.08, and revenue of $22.94 million versus $21.03 million expected. That shows continued execution and may help cushion the stock if investors focus on fundamentals rather than insider activity.
• Positive Sentiment: Analyst sentiment is still supportive overall, with a consensus rating of “Hold” and an average price target around $37.75, while several firms recently lifted targets into the high-$30s to $40 range. That suggests the market still sees upside potential if growth continues.
• Negative Sentiment: The stock is also trading below recent levels after moving sharply lower, which may reflect a broader reassessment of valuation after a strong run and the recent insider selling headlines.

Analyst Ratings Changes

AIP has been the topic of a number of research reports. Rosenblatt Securities increased their target price on shares of Arteris from $20.00 to $38.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Jefferies Financial Group upped their price objective on Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a research report on Wednesday, May 13th. TD Cowen lifted their target price on Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Weiss Ratings cut Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Finally, Wall Street Zen downgraded Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $37.75.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.